Pediatrix Medical Group (NYSE:MD – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12, Zacks reports. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million.
Pediatrix Medical Group Stock Down 9.6 %
NYSE MD opened at $15.57 on Friday. The stock’s fifty day moving average price is $13.89 and its 200 day moving average price is $12.96. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $17.67.
Analyst Ratings Changes
A number of analysts recently issued reports on MD shares. UBS Group raised their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday. Macquarie initiated coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price target for the company. Jefferies Financial Group lifted their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Truist Financial lifted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $17.08.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
- Five stocks we like better than Pediatrix Medical Group
- Pros And Cons Of Monthly Dividend Stocks
- Gilead Sciences: 4 Reasons This Stock Has Much More To Rise
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 02/17 – 02/21
- With Risk Tolerance, One Size Does Not Fit All
- SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.